We focused on targeting GFAPPOS cells, as the GFAP marker is strongly present at the tumor site in GB patients.69 Elevated expression of GFAP has been reported in both malignant cells, predominantly in astrocyte-like cells,70,71 and in reactive astrocytes around the tumor (Figures S8A and S8B). The gene discussed is GFAP; the disease is neoplasm.